Search

everythinglearnresearchcommunity

for

Search:↓

The HR protein's role as a repressor is essential for controlling hair growth.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Inhibiting ODC can prevent UV-induced skin cancer.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

The nanohybrid system significantly improved wound healing and showed strong antibacterial activity.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.